Northwestern Team Receives Grant to Develop Virus-Deactivating Mask

Through innovation, hard work and a $200,000 grant from the National Science Foundation, a research team led by chemistry Prof. Omar Farha will work to develop a reusable, virus-deactivating face mask for healthcare workers on the frontlines of the COVID-19 pandemic.

According to a May

...

Continue Reading

First EpiShuttle has landed in France

The isolation pod known as the EpiShuttle has finally reached France for evaluation from professional caretakers and medical transport. France is still comping with a large amount of corona patients and high rates of critical cases.

The EpiShuttle is already in service with The

...

Continue Reading

USAF Testing Newly Developed System to Fly Infectious Patients

On April 21 a joint Air Force team, led by the Air Force Life Cycle Management Center and the Air Force’s CBRN Defense Systems Branch, delivered a rapidly developed containment system prototype that will enable as many as 28 COVID-positive patients to be transported aboard a C-17 in response to

...

Continue Reading

EpiShuttles to Protect Patients and Crews

From next week, two DRF Luftrettung stations in Germany will be using “EpiShuttles”, a special insulation stretcher. Another eight stations are to follow soon.

DRF Luftrettung invests in the protection of patients and their crews so that they can continue to help people in medical

...

Continue Reading

SwRI receives $9.9 million to develop nerve agent antidote

Southwest Research Institute has received funding from the Medical CBRN Defense Consortium (MCDC) administered by Advanced Technology International to develop a nerve agent antidote for emergency use on the battlefield or to protect public health.

The use of nerve agents continues to be

...

Continue Reading

Inovio Receives $5M Grant for COVID-19 Vaccine Delivery Device

INOVIO Pharmaceuticals, Inc. (NASDAQ:INO) announced today that it has received a new $5 million grant from the Bill & Melinda Gates Foundation to accelerate the testing and scale up of CELLECTRA® 3PSP proprietary smart device for the intradermal delivery of INO-4800, a DNA vaccine for

...

Continue Reading

ERVEBO Now Registered in Four African Countries

Merckhas confirmed that ERVEBO has now been registered by National Health Authorities in the following countries in Africa – DRC, Burundi, Ghana, and Zambia. 

ERVEBO was granted a conditional marketing authorization by the European Commission on November 11, 2019 and approved by

...

Continue Reading

CEPI grants $9M to Inovio to develop coronavirus vaccine

Inovio Pharmaceuticals, USA has announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded Inovio a grant of up to $9 million to develop a vaccine against the recently emerged strain of coronavirus (2019-nCoV). This initial CEPI funding will support Inovio's

...

Continue Reading

Elmon Release CBRN Suit

Elmon  is a leading manufacture of Ballistic (bulletproof) protection. For the last five years Elmon have been working on developing and adding CBRN suits to be included with its products, and are proud about the launching their very own CBRN protection suite with respirator,

...

Continue Reading

Ebola vaccine safety to be studied 5 years post vaccination

The Partnership for Research on Ebola Vaccination (PREVAC) has launched a project called PREVAC-UP with the aim of evaluating three Ebola vaccine regimens for five years after vaccination.

The study will assess several factors of these treaments

  • long-term
...

Continue Reading

Pentagon Presses for Access to Special EU Defense Projects

David Norquist, the U.S. Deputy Defense Secretary, has said that American Defense firms should not be cut out of European Union programs to strengthen its industrial base, such as the European Defence Fund and the Permanent Structured Cooperation program. 

Speaking at the

...

Continue Reading

Merck's Ebola Vaccine Granted Conditional Approval in the EU

Merck , known as MSD outside the United States and Canada, today announced that the European Commission has granted a conditional marketing authorization to ERVEBO for active immunization of individuals 18 years of age or older to protect against Ebola Virus Disease (EVD) caused by Zaire Ebola

...

Continue Reading

FDA Clears First Rapid Diagnostic Test for Ebola

The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) on Thursday allowed the marketing of the first rapid diagnostic test for the Ebola virus that has not been authorized via the agency’s Emergency Use Authorization (EUA) pathway.
...

Continue Reading

NIOSH Releases First Responder Illicit Drug Toolkit

The National Institute for Occupational Safety and Health (NIOSH) has released a new virtual toolkit to help first responders reduce their exposure to fentanyl and other illicit drugs. The toolkit provides resources to help keep first responders safe when arriving on a scene where illicit

...

Continue Reading

FLIR Aquires Tethered Drone Assets and Technology from Aria Insights

FLIR Systems, Inc. has announced that it has acquired the intellectual property (IP) and certain operating assets of Aria Insights, Inc. Terms of the deal are not being disclosed.

Previously known as CyPhy Works, Inc., Aria pioneered the development of tethered small unmanned aerial

...

Continue Reading

Ebola Therapy mAb114 Receives $14 million in Funding

It was annonuced on September 24th that the Biomedical Advanced Research and Development Authority (BARDA) intends to provide $14 millio, as well as expertise support for the advanced development of an investigational Ebola treatment being pursued by Ridgeback Biotherapeutics of

...

Continue Reading

FDA Approve Smallpox/Monkeypox Vaccine

The FDA has approved the Jynneos vaccine by Bavarian Nordic for the prevention of Smallpox and Monkeypox in adults 18 years of age and older determined to be at high risk for these infections.

Jynneos is a live vaccine produced from the strain Modified Vaccinia Ankara-Bavarian Nordic

...

Continue Reading

MCDC Award $20 Million Contract for Development of Auto-Injector

Emergent BioSolutions Inc.  announced on September 25th that it has been awarded approximately $20 million to develop and manufacture an auto-injector containing diazepam (5 mg/mL) to treat nerve agent-induced seizures. Emergent’s device is being designed for intramuscular

...

Continue Reading

LLNL Nerve Agent Antidote Shows Great Potential

Scientists at the Lawrence Livermore National Laboratory have been working with live agent, supercomputers, and accelerated mass spectrometry, to develop a new nerve agent antidote, namely LLNL-02. 

Their work has been showing great promise, and with somw refinement of

...

Continue Reading

HHS Funds an Additional Year of Ebola Vaccine Manufacturing

As part of the international response to the Ebola virus outbreak in the Democratic Republic of the Congo (DRC) and to meet domestic biodefense goals, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) will support

...

Continue Reading

Our Current Sponsors